`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`CIVIL ACTION
`
`NO. 22-252
`
`:
`:
`:
`:
`:
`:
`:
`:
`
`ORDER
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GMBH,
`
`
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`
`
`
`
`
`
`
`
`
`v.
`
`
`
`
`
`
`
`
`
`
`
`MODERNA, INC. and MODERNATX, INC.,
`
`
`
`
`
`
`
`
`
`
`
`AND NOW, this 27th day of February, 2024, upon consideration of Plaintiffs’ Discovery
`
`Dispute letters (D.I. 161, 184, 206) and Defendant’s Responses (D.I. 183, 196, 212), and following
`
`a discovery hearing, it is hereby ORDERED that:
`
`1. With respect to the timing of Defendant’s production of samples,
`
`a. Within fourteen (14) days from the date of this Order, Defendant shall
`
`produce to Plaintiffs all remaining information about batch/lot numbers;
`
`b. Within fourteen (14) days from the date of this Order, Defendant shall
`
`produce all samples from the three lots/batches selected by Defendant; and
`
`c. Within twenty-one (21) days from the date that Plaintiffs identifies the
`
`three lots/batches it has selected for sampling, Defendant shall produce all
`
`samples from those lots/batches.
`
`2. With respect to Plaintiffs’ request to preclude Defendant from making arguments
`
`about the applicability of test data generated by Plaintiffs for any lot based on its
`
`expiration date, that request is denied as premature without prejudice to
`
`Plaintiffs’ right to re-raise this issue through motions in limine.
`
`3. With respect to Plaintiffs’ request for SM-102 LNP samples and related data,
`
`
`
`Case 1:22-cv-00252-MSG Document 229 Filed 02/27/24 Page 2 of 3 PageID #: 15342
`
`a. As to Plaintiffs’ request for samples, counsel are instructed to meet and
`
`confer regarding Plaintiff’s proposed compromise. If the parties are unable
`
`to reach an agreement, Plaintiffs may re-raise this issue with the Court; and
`
`b. As to certificates of analysis, Defendant shall complete production of all
`
`certificates of analysis showing SM-102 LNP lipid content. Plaintiffs must
`
`engage in a thorough review of the produced regulatory information, and, if
`
`they believe it is insufficient, Plaintiffs may re-raise this issue with the Court
`
`and establish how the need for the raw data underlying the certificates of
`
`analysis outweigh any undue burden on Defendants.
`
`4. With respect to Plaintiffs’ request for INDs for non-accused products, Defendant
`
`shall select three INDs that have molar ratios similar to the accused product and
`
`produce the Chemistry, Manufacturing, and Controls sections for each of those
`
`INDs. Following review of those documents, Plaintiffs may, if necessary, request
`
`additional INDs but only with a specific and detailed showing of need.
`
`5. With respect to Plaintiffs’ request for sales information about vaccines
`
`manufactured abroad and sold abroad, Plaintiffs shall propound to Defendant
`
`specific interrogatories about such sales that are narrowly-tailored to the factors
`
`enumerated in Halo Electronics, Inc. v. Pulse Electronics, Inc., 831 F.3d 1369 (Fed.
`
`Cir. 2016). After review of Defendant’s responses, if Plaintiffs are able to
`
`demonstrate that a specific sale could be deemed a “U.S. Sale,” they may renew
`
`their request for documents as to that sale.
`
`
`
`Case 1:22-cv-00252-MSG Document 229 Filed 02/27/24 Page 3 of 3 PageID #: 15343
`
`6. With respect to Plaintiffs’ request for Board of Directors’ Minutes and Materials
`
`Concerning the Accused Product, this request is denied as moot in light of the
`
`parties’ agreement on this issue.
`
`7. With respect to Plaintiffs’ request for litigation deposition transcripts of Moderna
`
`witnesses from Moderna v. Pfizer, No. 22-cv-11378 (D. Mass) and Alnylam v.
`
`Moderna, No. 22-cv-335 (D. Del.), Plaintiffs’ request is denied as moot in light of
`
`the parties’ agreement on this issue.
`
`8. With respect to Plaintiffs’ request for documents from litigation in Moderna v.
`
`Pfizer, No. 22-cv-11378 (D. Mass), Plaintiffs’ request is denied as moot in light of
`
`the parties’ agreement on this issue.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`BY THE COURT:
`
`
`
`/s/ Mitchell S. Goldberg
`MITCHELL S. GOLDBERG, J.
`
`
`
`